Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboembolism in inflammatory bowel disease.

M Schapira1, J Henrion, C Ravoet

  • 1Department of Internal Medicine, Clinique de Jolimont, Haine St Paul, Belgium.

Acta Gastro-Enterologica Belgica
|July 31, 1999
PubMed
Summary

Inflammatory bowel disease (IBD) increases the risk of thromboembolism, particularly in young patients with active disease. Prompt anticoagulation is crucial for managing these events and may improve IBD outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microscopic colitis related to food supplement containing turmeric: a review of 3 cases.

Acta gastro-enterologica Belgica·2024
Same author

Clinical characteristics of hepatocellular carcinoma in patients with cirrhosis: a comparative cohort study.

Acta gastro-enterologica Belgica·2023
Same author

5-year mortality of alcohol-related cirrhosis: patients die just as much but not in the same manner.

Acta gastro-enterologica Belgica·2022
Same author

Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.

Acta gastro-enterologica Belgica·2022
Same author

[Vascular damage and cognitive-functional performance in a population with mild cognitive impairment].

Revista de neurologia·2022
Same author

Systematic analysis of the interactions driving small molecule-RNA recognition.

RSC medicinal chemistry·2021

Area of Science:

  • Gastroenterology and Hematology
  • Vascular Medicine
  • Inflammatory Diseases

Background:

  • Inflammatory bowel disease (IBD) is associated with a significant risk of thromboembolic events, especially in young adults with active disease.
  • The prothrombotic state in IBD involves alterations in multiple coagulation parameters.
  • Deep venous thrombosis and pulmonary embolism are the most common manifestations, while arterial complications are less frequent.

Purpose of the Study:

  • To highlight the link between inflammatory bowel disease and thromboembolism.
  • To emphasize the prothrombotic nature of active IBD.
  • To underscore the importance of anticoagulation in managing IBD-related thromboembolic complications.

Main Methods:

  • Review of existing literature on thromboembolism in inflammatory bowel disease.

Related Experiment Videos

  • Analysis of coagulation parameters in IBD patients.
  • Clinical case observations regarding thromboembolic events and their management.

    • Main Results:

    • Inflammatory bowel disease significantly elevates the risk of thromboembolism, with a predilection for young patients experiencing active disease.
    • Coagulation system activation is a hallmark of IBD, creating a prothrombotic environment.
    • While deep venous thrombosis and pulmonary embolism are common, arterial and unusual site thromboembolisms also occur.

    Conclusions:

    • Inflammatory bowel disease is a prothrombotic condition requiring vigilant thromboembolism screening and management.
    • Anticoagulation therapy is mandatory for thromboembolic episodes in IBD patients.
    • Effective anticoagulation may potentially improve the clinical course of inflammatory bowel disease itself.